0001363213-16-000074.txt : 20160413
0001363213-16-000074.hdr.sgml : 20160413
20160413105502
ACCESSION NUMBER: 0001363213-16-000074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160411
FILED AS OF DATE: 20160413
DATE AS OF CHANGE: 20160413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blobel Friedhelm
CENTRAL INDEX KEY: 0001363213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 161568604
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-04-11
0
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001363213
Blobel Friedhelm
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404
1
1
0
0
President & CEO
Common Stock
2016-04-11
4
M
0
160640.0
2.49
A
365892
D
Common Stock
2016-04-11
4
F
0
99260.0
12.39
D
266632
D
Common Stock
2016-04-11
4
M
0
499160.0
2.49
A
765792
D
Common Stock
2016-04-11
4
F
0
306510.0
12.39
D
459282
D
Incentive Stock Option (right to buy)
2.49
2016-04-11
4
M
0
160640.0
0.0
D
2016-06-02
Common Stock
160640
0
D
Non-Qualified Stock Option (right to buy)
2.49
2016-04-11
4
M
0
499160.0
0.0
D
2016-06-02
Common Stock
499160
0
D
Shares disposed represent shares withheld to cover withholding tax obligations and the exercise price in connection with the exercise of the options.
Granted under the Issuer's 2005 Equity Incentive Plan.
Provided the reporting person remains employed by or acting as a consultant to the Company, the option will become exercisable in four equal annual installments on 6/02/07, 6/02/08, 6/02/09 and 6/02/10.
1/36th of the outstanding options shall vest monthly over a three year period, with initial vesting occurring on June 1, 2010.
/s/ Friedhelm Blobel, Ph.D.
2016-04-13